<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02874495</url>
  </required_header>
  <id_info>
    <org_study_id>38RC11.220</org_study_id>
    <nct_id>NCT02874495</nct_id>
  </id_info>
  <brief_title>Anticipation Effect on Painful Phenomenons Linked to Rectal Distension for Patients With a Crohn's Disease in Remission</brief_title>
  <acronym>Douleur IRMf</acronym>
  <official_title>Anticipation Effect on Painful Phenomenons Linked to Rectal Distension for Patients With a Crohn's Disease in Remission: Functional MRI Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Crohn's disease goes along with an alteration of the quality of life, even in remission and
      has a negative impact on stress management linked to the pain and the health. Conversely,
      stress and psychological variables play a significant role in the pathogenesis of this
      disease. These interrelations reflects the link between the brain and the digestive tract,
      called brain-gut axis. The autonomic nervous system (ANS) is the neurological interface,
      relaying in a bidirectional way, informations between the digestive tract and the central
      nervous system (CNS).

      Visceral information can thus modulate the functionnement of CNS's areas involved in pain
      management but also in the management of emotional and cognitive behaviours. Yet, numerous
      work demonstrate the existence of a dysfunction of the ANS during Crohn's disease, with a
      dysautonomia of the sympatho-vagal balance.

      Human brain respond by advance before and during the application of a painful stimulus that
      enable the organism to regulate its nociceptive system in order to handle the aversive
      stimulus incoming, via the activation of brin areas managing the pain, or the raise of pain
      awareness.

      The uncertain and not predictable nature of a painful crisis and/or an inflammatory relapse
      in a chronic disease like Crohn's disease can be the origin of an anticipating apprehension
      and anxiety, that could influence visceral perception (increasing it). Nevertheless, only few
      studies exists about the differential role of certain or uncertain anticipation of the pain,
      despite the fact that they are associated to different emotional, cognitive and behavioral
      responses, and the effect of anticipation on painful visceral perception, have not yet been
      studied for parents in remission of Crohn's disease.

      The main goal is to search during certain and uncertain visceral anticipation, induced by
      distension of an intra-rectal balloon for persons suffering from Crohn's disease in
      remission, compared to control subjects, with an MRI functional study
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Magnetic Resonance Imaging</measure>
    <time_frame>30 minutes</time_frame>
    <description>Activation of cortical cerebral structures involved in visceral pain and communication paths between them With a certain or uncertain anticipation phase of distension (warning light) followed or not by a rectal distension at the pain threshold previously determined, and then a retrospective quotation of pain during distension and the fear of pain induced by anticipation. Structural MRI and rest of functional connectivity measure MRI.
With measure of heart rate variability.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Heart Rate Variability</measure>
    <time_frame>30 minutes</time_frame>
    <description>During MRI session, from the electrocardiographic signal. (measure of variations on R-R interval in milliseconds ms).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychological tests</measure>
    <time_frame>45 minutes</time_frame>
    <description>Related to affective and cognitive dimensions of pain :
Questionnaire of personality inventory NEO-FFI (Bouvard, 2005)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychological tests</measure>
    <time_frame>45 minutes</time_frame>
    <description>Related to affective and cognitive dimensions of pain :
Questionnaire of depressive symptomatology CES-D (Center for Epidemiologic Studies-Depression Scale; Radloff, 1977)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychological tests</measure>
    <time_frame>45 minutes</time_frame>
    <description>Related to affective and cognitive dimensions of pain :
Anxiety inventory (STAI-Y of Spielberger)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychological tests</measure>
    <time_frame>45 minutes</time_frame>
    <description>Related to affective and cognitive dimensions of pain :
Pain Catastrophizing Scale of Sullivan 1995</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychological tests</measure>
    <time_frame>45 minutes</time_frame>
    <description>Related to affective and cognitive dimensions of pain :
Pain Anxiety Symptoms Scale of Cracken 1992</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychological tests</measure>
    <time_frame>45 minutes</time_frame>
    <description>Related to affective and cognitive dimensions of pain :
Fear of Pain Questionnaire of McNeil andRainwater ; 1998</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychological tests</measure>
    <time_frame>45 minutes</time_frame>
    <description>Related to affective and cognitive dimensions of pain :
Visceral Sensitivity Index of Labus; 2004</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychological tests</measure>
    <time_frame>45 minutes</time_frame>
    <description>Related to affective and cognitive dimensions of pain :
Questionnaire of Mindfulness, Walach 2006</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychological tests</measure>
    <time_frame>45 minutes</time_frame>
    <description>Related to affective and cognitive dimensions of pain :
Questionnaire for uncertainty intolerance (Freeston 1994)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychological tests</measure>
    <time_frame>45 minutes</time_frame>
    <description>Related to affective and cognitive dimensions of pain :
The Illness Attitude Scales, Dammen 1999</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychological tests</measure>
    <time_frame>45 minutes</time_frame>
    <description>Related to affective and cognitive dimensions of pain :
Childhood Trauma Questionnaire of Bernstein 2003</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychological tests</measure>
    <time_frame>45 minutes</time_frame>
    <description>Related to affective and cognitive dimensions of pain :
Ways of Coping Checklist Revised, adapted in French by Cousson 1996</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Crohn's Disease</condition>
  <arm_group>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <description>22 persons.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with Crohn's disease</arm_group_label>
    <description>22 patients.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Psychological tests</intervention_name>
    <description>Related to affective and cognitive dimensions of pain.</description>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>Patients with Crohn's disease</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Magnetic Resonance Imaging</intervention_name>
    <description>With a certain or uncertain anticipation phase of distension (warning light) followed or not by a rectal distension at the pain threshold previously determined, and then a retrospective quotation of pain during distension and the fear of pain induced by anticipation. Structural MRI and rest of functional connectivity measure MRI.
With measure of heart rate variability.</description>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>Patients with Crohn's disease</arm_group_label>
    <other_name>MRI</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Heart Rate Variability</intervention_name>
    <description>During MRI session, from the electrocardiographic signal. (measure of variations on R-R interval in milliseconds ms).</description>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>Patients with Crohn's disease</arm_group_label>
    <other_name>HRV</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Crohn's disease
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  For patients :

               -  Patients over 18 years and less than 60 years.

               -  Right-handed.

               -  Diagnosis of Crohn's disease established on clinical biological, endoscopic and
                  anatomopathological criteria.

               -  Ideal localization and/or diarrhea of Crohn's Disease, with an absence of rectal
                  or anoperineal ravages past or presents in order to not do distension on rectal/
                  and anoperineal lesions.

               -  Crohn's disease treatment authorize : 5-aminosalicylates since at least 4 weeks
                  with a stable dose since at least 2 weeks ; immunosuppressive drugs since at
                  least 12 weeks with a stable dose since at least 4 weeks ; anti-TNF since at
                  least 3 months with a stable dose since at least 1 month ; absence of
                  corticosteroid treatment since at least 15 days.

               -  Clinical remission : Crohn's Disease Activity Index (CDAI) &lt; 150 (Best 1976) and
                  biological : normal CRP and faecal calprotectin &lt; 100 g/g.

               -  Patient able to understand and follow necessary commissions for the conduct of
                  the clinical trial, and that have given his free written consent for this study.

               -  Registered to a French social security.

               -  The person won't be allow to participate simultaneously to another study and
                  there won't be an exclusion period to participation to a clinical or therapeutic
                  trial at the end of this study.

          -  For healthy volunteers

               -  Patients over 18 years and less than 60 years.

               -  Right-handed.

               -  Paired with patients for sex and age.

               -  Absence of digestive surgical or medical history except appendectomy,
                  hysterectomy, cholecystectomy, inguinal hernia cure and/or femoral.

               -  Absence of digestive symptomatology searched while a standardized interrogation.

               -  Clinical digestive exam normal.

               -  The person won't be allow to participate simultaneously to another study and
                  there won't be an exclusion period to. participation to a clinical or therapeutic
                  trial at the end of this study.

               -  Registered to a French social security.

               -  Registered to the national file of persons participating to biomedicals searches
                  without direct individual profit.

        Exclusion Criteria:

          -  Subjet under 18 years and more than 60 years.

          -  Counter-argument for MRI : presence of intra-corporeal ferro-magnetic particles,
             claustrophobia.

          -  Existence of a severe condition on general level (cardiac, respiratory, hematological,
             renal, hepatic, cancerous).

          -  Existence of an organic digestive affection (gastritis, gallstones, duodenal ulcer,
             megacolon, inflammatory colitis).

          -  Existence or history malignant gastrointestinal condition.

          -  History of abdominal digestive surgery except appendectomy, hysterectomy, cure of
             inguinal hernia)

          -  Recto-anal or périneal active pathology (haemorrhoid , anal fissure …).

          -  Presence of arectal fecal impaction.

          -  Patient included in an other clinical or therapeutic trial.

          -  Patient treated by a drug sensitive to modify sensitivity and/or digestive motor
             function.

          -  Patient regularly receiving psychotropic drugs (anxiolytics, sedatives,
             antidepressants, neuroleptics).

          -  Patient with a pathology that could modify visceral sensitivity like diabetes or
             neurodegenerative diseases.

          -  Persons concerned by articles L1121-5 to L1121-8 of CSP.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bruno Bonaz, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Grenoble Hospital University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bruno Bonaz, Professor</last_name>
    <phone>04.76.76.55.97</phone>
    <email>BBonaz@chu-grenoble.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amandine Rubio, Medical doctor</last_name>
    <phone>04.76.76.59.11</phone>
    <email>arubio@chu-grenoble.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UniversityHospitalGrenoble</name>
      <address>
        <city>La Tronche</city>
        <zip>38700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruno Bonaz, Professor</last_name>
      <phone>04.76.76.55.97</phone>
      <email>BBonaz@chu-grenoble.fr</email>
    </contact>
    <contact_backup>
      <last_name>Amandine Rubio, Medical doctor</last_name>
      <phone>04.76.76.59.11</phone>
      <email>arubio@chu-grenoble.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Achard S, Salvador R, Whitcher B, Suckling J, Bullmore E. A resilient, low-frequency, small-world human brain functional network with highly connected association cortical hubs. J Neurosci. 2006 Jan 4;26(1):63-72.</citation>
    <PMID>16399673</PMID>
  </reference>
  <reference>
    <citation>Al-Chaer ED, Lawand NB, Westlund KN, Willis WD. Visceral nociceptive input into the ventral posterolateral nucleus of the thalamus: a new function for the dorsal column pathway. J Neurophysiol. 1996 Oct;76(4):2661-74.</citation>
    <PMID>8899636</PMID>
  </reference>
  <reference>
    <citation>Ashburner J. Computational anatomy with the SPM software. Magn Reson Imaging. 2009;27(8):1163-74. Epub 2009 Feb 27. Review.Baciu MV, Bonaz BL, Papillon E, Bost RA, Le Bas JF, Fournet J, Segebarth CM. Central processing of rectal pain: a functional MR imaging study. AJNR Am J Neuroradiol. 1999;20(10):1920-4.</citation>
  </reference>
  <reference>
    <citation>Baciu MV, Bonaz BL, Papillon E, Bost RA, Le Bas JF, Fournet J, Segebarth CM. Central processing of rectal pain: a functional MR imaging study. AJNR Am J Neuroradiol. 1999 Nov-Dec;20(10):1920-4.</citation>
    <PMID>10588119</PMID>
  </reference>
  <reference>
    <citation>Baert F, Moortgat L, Van Assche G, Caenepeel P, Vergauwe P, De Vos M, Stokkers P, Hommes D, Rutgeerts P, Vermeire S, D'Haens G; Belgian Inflammatory Bowel Disease Research Group; North-Holland Gut Club. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease. Gastroenterology. 2010 Feb;138(2):463-8; quiz e10-1. doi: 10.1053/j.gastro.2009.09.056. Epub 2009 Oct 8.</citation>
    <PMID>19818785</PMID>
  </reference>
  <reference>
    <citation>Benarroch EE. The central autonomic network: functional organization, dysfunction, and perspective. Mayo Clin Proc. 1993 Oct;68(10):988-1001. Review.</citation>
    <PMID>8412366</PMID>
  </reference>
  <reference>
    <citation>Berman SM, Naliboff BD, Suyenobu B, Labus JS, Stains J, Ohning G, Kilpatrick L, Bueller JA, Ruby K, Jarcho J, Mayer EA. Reduced brainstem inhibition during anticipated pelvic visceral pain correlates with enhanced brain response to the visceral stimulus in women with irritable bowel syndrome. J Neurosci. 2008 Jan 9;28(2):349-59. doi: 10.1523/JNEUROSCI.2500-07.2008.</citation>
    <PMID>18184777</PMID>
  </reference>
  <reference>
    <citation>Bernstein DP, Stein JA, Newcomb MD, Walker E, Pogge D, Ahluvalia T, Stokes J, Handelsman L, Medrano M, Desmond D, Zule W. Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse Negl. 2003 Feb;27(2):169-90.</citation>
    <PMID>12615092</PMID>
  </reference>
  <reference>
    <citation>Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976 Mar;70(3):439-44.</citation>
    <PMID>1248701</PMID>
  </reference>
  <reference>
    <citation>Biswal BB, Mennes M, Zuo XN, Gohel S, Kelly C, Smith SM, Beckmann CF, Adelstein JS, Buckner RL, Colcombe S, Dogonowski AM, Ernst M, Fair D, Hampson M, Hoptman MJ, Hyde JS, Kiviniemi VJ, Kötter R, Li SJ, Lin CP, Lowe MJ, Mackay C, Madden DJ, Madsen KH, Margulies DS, Mayberg HS, McMahon K, Monk CS, Mostofsky SH, Nagel BJ, Pekar JJ, Peltier SJ, Petersen SE, Riedl V, Rombouts SA, Rypma B, Schlaggar BL, Schmidt S, Seidler RD, Siegle GJ, Sorg C, Teng GJ, Veijola J, Villringer A, Walter M, Wang L, Weng XC, Whitfield-Gabrieli S, Williamson P, Windischberger C, Zang YF, Zhang HY, Castellanos FX, Milham MP. Toward discovery science of human brain function. Proc Natl Acad Sci U S A. 2010 Mar 9;107(10):4734-9. doi: 10.1073/pnas.0911855107. Epub 2010 Feb 22.</citation>
    <PMID>20176931</PMID>
  </reference>
  <reference>
    <citation>Bitton A, Dobkin PL, Edwardes MD, Sewitch MJ, Meddings JB, Rawal S, Cohen A, Vermeire S, Dufresne L, Franchimont D, Wild GE. Predicting relapse in Crohn's disease: a biopsychosocial model. Gut. 2008 Oct;57(10):1386-92. doi: 10.1136/gut.2007.134817. Epub 2008 Apr 7.</citation>
    <PMID>18390994</PMID>
  </reference>
  <reference>
    <citation>Blankstein U, Chen J, Diamant NE, Davis KD. Altered brain structure in irritable bowel syndrome: potential contributions of pre-existing and disease-driven factors. Gastroenterology. 2010 May;138(5):1783-9. doi: 10.1053/j.gastro.2009.12.043. Epub 2010 Jan 4.</citation>
    <PMID>20045701</PMID>
  </reference>
  <reference>
    <citation>Bonaz B, Plourde V, Taché Y. Abdominal surgery induces Fos immunoreactivity in the rat brain. J Comp Neurol. 1994 Nov 8;349(2):212-22.</citation>
    <PMID>7860779</PMID>
  </reference>
  <reference>
    <citation>Bonaz B, Taché Y. Induction of Fos immunoreactivity in the rat brain after cold-restraint induced gastric lesions and fecal excretion. Brain Res. 1994 Jul 25;652(1):56-64.</citation>
    <PMID>7953723</PMID>
  </reference>
  <reference>
    <citation>Bonaz B, Taché Y. Water-avoidance stress-induced c-fos expression in the rat brain and stimulation of fecal output: role of corticotropin-releasing factor. Brain Res. 1994 Mar 28;641(1):21-8.</citation>
    <PMID>8019847</PMID>
  </reference>
  <reference>
    <citation>Bonaz B, Rivière PJ, Sinniger V, Pascaud X, Junien JL, Fournet J, Feuerstein C. Fedotozine, a kappa-opioid agonist, prevents spinal and supra-spinal Fos expression induced by a noxious visceral stimulus in the rat. Neurogastroenterol Motil. 2000 Apr;12(2):135-47.</citation>
    <PMID>10771495</PMID>
  </reference>
  <reference>
    <citation>Bonaz B, Baciu M, Papillon E, Bost R, Gueddah N, Le Bas JF, Fournet J, Segebarth C. Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study. Am J Gastroenterol. 2002 Mar;97(3):654-61.</citation>
    <PMID>11926209</PMID>
  </reference>
  <reference>
    <citation>Bonaz B, Sabate JM. [Brain-gut axis dysfunction]. Gastroenterol Clin Biol. 2009 Feb;33 Suppl 1:S48-58. doi: 10.1016/S0399-8320(09)71525-8. French.</citation>
    <PMID>19303539</PMID>
  </reference>
  <reference>
    <citation>Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000 May 25;405(6785):458-62.</citation>
    <PMID>10839541</PMID>
  </reference>
  <reference>
    <citation>Bouin M, Plourde V, Boivin M, Riberdy M, Lupien F, Laganière M, Verrier P, Poitras P. Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology. 2002 Jun;122(7):1771-7.</citation>
    <PMID>12055583</PMID>
  </reference>
  <reference>
    <citation>Boureau F, Luu M, Doubrere JF, Gay C. [Construction of a questionnaire for the self-evaluation of pain using a list of qualifiers. Comparison with Melzack's McGill Pain Questionnaire]. Therapie. 1984 Mar-Apr;39(2):119-29. French.</citation>
    <PMID>6729763</PMID>
  </reference>
  <reference>
    <citation>Bouvard, M., Cottreaux, J. Protocoles et échelles d'évaluation en psychiatrie et en psychologie. 4ème Ed, 2005 Masson.</citation>
  </reference>
  <reference>
    <citation>Collins SM. Stress and the Gastrointestinal Tract IV. Modulation of intestinal inflammation by stress: basic mechanisms and clinical relevance. Am J Physiol Gastrointest Liver Physiol. 2001 Mar;280(3):G315-8. Review.</citation>
    <PMID>11171612</PMID>
  </reference>
  <reference>
    <citation>Cousson, F, Bruchon-Schweitzer, M, Quintard, B, Nuissier, J, Rascle N. Analyse multidimensionnelle d'une échelle de coping: validation française de la WCC (Ways of Coping Checklist). Psychologie Française 1996 ; 41: 155-164.</citation>
  </reference>
  <reference>
    <citation>Dammen T, Friis S, Ekeberg O. The Illness Attitude Scales in chest pain patients: a study of psychometric properties. J Psychosom Res. 1999 Apr;46(4):335-42.</citation>
    <PMID>10340232</PMID>
  </reference>
  <reference>
    <citation>Ducrotté P, Bonaz B. Stress et tube digestif dans Stress, Pathologies et Immunité. Thurin JM et Bauman N. Ed Flammarion Médecine-Sciences, 2003 : p181-189.</citation>
  </reference>
  <reference>
    <citation>Fairhurst M, Wiech K, Dunckley P, Tracey I. Anticipatory brainstem activity predicts neural processing of pain in humans. Pain. 2007 Mar;128(1-2):101-10. Epub 2006 Oct 27.</citation>
    <PMID>17070996</PMID>
  </reference>
  <reference>
    <citation>Faure C, Giguère L. Functional gastrointestinal disorders and visceral hypersensitivity in children and adolescents suffering from Crohn's disease. Inflamm Bowel Dis. 2008 Nov;14(11):1569-74. doi: 10.1002/ibd.20506.</citation>
    <PMID>18521915</PMID>
  </reference>
  <reference>
    <citation>Freeston, M. H., Rheaume, J., Letarte, H., Dugas, M. J., &amp; Ladouceur, R. Why do people worry? Personality and Individual Differences, 1994, 17, 791-802.</citation>
  </reference>
  <reference>
    <citation>Geboes K, Collins S. Structural abnormalities of the nervous system in Crohn's disease and ulcerative colitis. Neurogastroenterol Motil. 1998 Jun;10(3):189-202. Review.</citation>
    <PMID>9659662</PMID>
  </reference>
  <reference>
    <citation>Gillanders S, Wild M, Deighan C, Gillanders D. Emotion regulation, affect, psychosocial functioning, and well-being in hemodialysis patients. Am J Kidney Dis. 2008 Apr;51(4):651-62. doi: 10.1053/j.ajkd.2007.12.023.</citation>
    <PMID>18371541</PMID>
  </reference>
  <reference>
    <citation>Graff LA, Walker JR, Clara I, Lix L, Miller N, Rogala L, Rawsthorne P, Bernstein CN. Stress coping, distress, and health perceptions in inflammatory bowel disease and community controls. Am J Gastroenterol. 2009 Dec;104(12):2959-69. doi: 10.1038/ajg.2009.529. Epub 2009 Sep 15.</citation>
    <PMID>19755973</PMID>
  </reference>
  <reference>
    <citation>Guthrie E, Jackson J, Shaffer J, Thompson D, Tomenson B, Creed F. Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease. Am J Gastroenterol. 2002 Aug;97(8):1994-9.</citation>
    <PMID>12190166</PMID>
  </reference>
  <reference>
    <citation>Hagmann P, Jonasson L, Maeder P, Thiran JP, Wedeen VJ, Meuli R. Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyond. Radiographics. 2006 Oct;26 Suppl 1:S205-23. Review.</citation>
    <PMID>17050517</PMID>
  </reference>
  <reference>
    <citation>Isaacs KL. How rapidly should remission be achieved? Dig Dis. 2010;28(3):548-55. doi: 10.1159/000320415. Epub 2010 Sep 30. Review.</citation>
    <PMID>20926885</PMID>
  </reference>
  <reference>
    <citation>Kiebles JL, Doerfler B, Keefer L. Preliminary evidence supporting a framework of psychological adjustment to inflammatory bowel disease. Inflamm Bowel Dis. 2010 Oct;16(10):1685-95. doi: 10.1002/ibd.21215.</citation>
    <PMID>20155849</PMID>
  </reference>
  <reference>
    <citation>Labus JS, Mayer EA, Chang L, Bolus R, Naliboff BD. The central role of gastrointestinal-specific anxiety in irritable bowel syndrome: further validation of the visceral sensitivity index. Psychosom Med. 2007 Jan;69(1):89-98.</citation>
    <PMID>17244851</PMID>
  </reference>
  <reference>
    <citation>Lembo T, Munakata J, Mertz H, Niazi N, Kodner A, Nikas V, Mayer EA. Evidence for the hypersensitivity of lumbar splanchnic afferents in irritable bowel syndrome. Gastroenterology. 1994 Dec;107(6):1686-96. Erratum in: Gastroenterology 1997 Sep;113(3):1054.</citation>
    <PMID>7958680</PMID>
  </reference>
  <reference>
    <citation>Li J, Nørgard B, Precht DH, Olsen J. Psychological stress and inflammatory bowel disease: a follow-up study in parents who lost a child in Denmark. Am J Gastroenterol. 2004 Jun;99(6):1129-33.</citation>
    <PMID>15180736</PMID>
  </reference>
  <reference>
    <citation>Lix LM, Graff LA, Walker JR, Clara I, Rawsthorne P, Rogala L, Miller N, Ediger J, Pretorius T, Bernstein CN. Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease. Inflamm Bowel Dis. 2008 Nov;14(11):1575-84. doi: 10.1002/ibd.20511.</citation>
    <PMID>18512245</PMID>
  </reference>
  <reference>
    <citation>Lomax AE, Fernández E, Sharkey KA. Plasticity of the enteric nervous system during intestinal inflammation. Neurogastroenterol Motil. 2005 Feb;17(1):4-15. Review.</citation>
    <PMID>15670258</PMID>
  </reference>
  <reference>
    <citation>Mansfield P. Real-time echo-planar imaging by NMR. Br Med Bull. 1984 Apr;40(2):187-90.</citation>
    <PMID>6744006</PMID>
  </reference>
  <reference>
    <citation>McCracken LM, Zayfert C, Gross RT. The Pain Anxiety Symptoms Scale: development and validation of a scale to measure fear of pain. Pain. 1992 Jul;50(1):67-73.</citation>
    <PMID>1513605</PMID>
  </reference>
  <reference>
    <citation>McNeil DW, Rainwater AJ 3rd. Development of the Fear of Pain Questionnaire--III. J Behav Med. 1998 Aug;21(4):389-410.</citation>
    <PMID>9789168</PMID>
  </reference>
  <reference>
    <citation>Meregnani J, Clarençon D, Vivier M, Peinnequin A, Mouret C, Sinniger V, Picq C, Job A, Canini F, Jacquier-Sarlin M, Bonaz B. Anti-inflammatory effect of vagus nerve stimulation in a rat model of inflammatory bowel disease. Auton Neurosci. 2011 Feb 24;160(1-2):82-9. doi: 10.1016/j.autneu.2010.10.007. Epub 2010 Nov 11.</citation>
    <PMID>21071287</PMID>
  </reference>
  <reference>
    <citation>Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology. 1995 Jul;109(1):40-52. Erratum in: Gastroenterology 1997 Sep;113(3):1054.</citation>
    <PMID>7797041</PMID>
  </reference>
  <reference>
    <citation>Minderhoud IM, Oldenburg B, Wismeijer JA, van Berge Henegouwen GP, Smout AJ. IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci. 2004 Mar;49(3):469-74.</citation>
    <PMID>15139501</PMID>
  </reference>
  <reference>
    <citation>Ogawa S, Lee TM, Nayak AS, Glynn P. Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn Reson Med. 1990 Apr;14(1):68-78.</citation>
    <PMID>2161986</PMID>
  </reference>
  <reference>
    <citation>Ohlsson B, Sundkvist G, Lindgren S. Subclinical sympathetic neuropathy appears early in the course of Crohn's disease. BMC Gastroenterol. 2007 Aug 14;7:33.</citation>
    <PMID>17697346</PMID>
  </reference>
  <reference>
    <citation>Pavlov VA, Wang H, Czura CJ, Friedman SG, Tracey KJ. The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol Med. 2003 May-Aug;9(5-8):125-34. Review.</citation>
    <PMID>14571320</PMID>
  </reference>
  <reference>
    <citation>Pellissier S, Dantzer C, Canini F, Mathieu N, Bonaz B. Psychological adjustment and autonomic disturbances in inflammatory bowel diseases and irritable bowel syndrome. Psychoneuroendocrinology. 2010 Jun;35(5):653-62. doi: 10.1016/j.psyneuen.2009.10.004. Epub 2009 Nov 11.</citation>
    <PMID>19910123</PMID>
  </reference>
  <reference>
    <citation>Persoons P, Vermeire S, Demyttenaere K, Fischler B, Vandenberghe J, Van Oudenhove L, Pierik M, Hlavaty T, Van Assche G, Noman M, Rutgeerts P. The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab. Aliment Pharmacol Ther. 2005 Jul 15;22(2):101-10.</citation>
    <PMID>16011668</PMID>
  </reference>
  <reference>
    <citation>Petrak F, Hardt J, Clement T, Börner N, Egle UT, Hoffmann SO. Impaired health-related quality of life in inflammatory bowel diseases: psychosocial impact and coping styles in a national German sample. Scand J Gastroenterol. 2001 Apr;36(4):375-82.</citation>
    <PMID>11336162</PMID>
  </reference>
  <reference>
    <citation>Piche T, Ducrotté P, Sabate JM, Coffin B, Zerbib F, Dapoigny M, Hua M, Marine-Barjoan E, Dainese R, Hébuterne X. Impact of functional bowel symptoms on quality of life and fatigue in quiescent Crohn disease and irritable bowel syndrome. Neurogastroenterol Motil. 2010 Jun;22(6):626-e174. doi: 10.1111/j.1365-2982.2010.01502.x. Epub 2010 Apr 19.</citation>
    <PMID>20403099</PMID>
  </reference>
  <reference>
    <citation>Ploghaus A, Tracey I, Gati JS, Clare S, Menon RS, Matthews PM, Rawlins JN. Dissociating pain from its anticipation in the human brain. Science. 1999 Jun 18;284(5422):1979-81.</citation>
    <PMID>10373114</PMID>
  </reference>
  <reference>
    <citation>Ploghaus A, Becerra L, Borras C, Borsook D. Neural circuitry underlying pain modulation: expectation, hypnosis, placebo. Trends Cogn Sci. 2003 May;7(5):197-200.</citation>
    <PMID>12757820</PMID>
  </reference>
  <reference>
    <citation>Porro CA, Baraldi P, Pagnoni G, Serafini M, Facchin P, Maieron M, Nichelli P. Does anticipation of pain affect cortical nociceptive systems? J Neurosci. 2002 Apr 15;22(8):3206-14.</citation>
    <PMID>11943821</PMID>
  </reference>
  <reference>
    <citation>Posserud I, Syrous A, Lindström L, Tack J, Abrahamsson H, Simrén M. Altered rectal perception in irritable bowel syndrome is associated with symptom severity. Gastroenterology. 2007 Oct;133(4):1113-23. Epub 2007 Jul 25.</citation>
    <PMID>17919487</PMID>
  </reference>
  <reference>
    <citation>Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1977 ; 3 : 385-401.</citation>
  </reference>
  <reference>
    <citation>Reber SO, Obermeier F, Straub RH, Falk W, Neumann ID. Chronic intermittent psychosocial stress (social defeat/overcrowding) in mice increases the severity of an acute DSS-induced colitis and impairs regeneration. Endocrinology. 2006 Oct;147(10):4968-76. Epub 2006 Jun 22. Erratum in: Endocrinology. 2007 May;148(5):2065. Straub, H R [corrected to Straub, R H].</citation>
    <PMID>16794011</PMID>
  </reference>
  <reference>
    <citation>Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut. 1973 Feb;14(2):125-32.</citation>
    <PMID>4696535</PMID>
  </reference>
  <reference>
    <citation>Saper CB. The central autonomic nervous system: conscious visceral perception and autonomic pattern generation. Annu Rev Neurosci. 2002;25:433-69. Epub 2002 Mar 25. Review.</citation>
    <PMID>12052916</PMID>
  </reference>
  <reference>
    <citation>Schnitzler F, Fidder H, Ferrante M, Noman M, Arijs I, Van Assche G, Hoffman I, Van Steen K, Vermeire S, Rutgeerts P. Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease. Inflamm Bowel Dis. 2009 Sep;15(9):1295-301. doi: 10.1002/ibd.20927.</citation>
    <PMID>19340881</PMID>
  </reference>
  <reference>
    <citation>Schoepfer AM, Trummler M, Seeholzer P, Seibold-Schmid B, Seibold F. Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies. Inflamm Bowel Dis. 2008 Jan;14(1):32-9.</citation>
    <PMID>17924558</PMID>
  </reference>
  <reference>
    <citation>Schweinhardt P, Bushnell MC. Pain imaging in health and disease--how far have we come? J Clin Invest. 2010 Nov;120(11):3788-97. doi: 10.1172/JCI43498. Epub 2010 Nov 1. Review.</citation>
    <PMID>21041961</PMID>
  </reference>
  <reference>
    <citation>Seminowicz DA, Labus JS, Bueller JA, Tillisch K, Naliboff BD, Bushnell MC, Mayer EA. Regional gray matter density changes in brains of patients with irritable bowel syndrome. Gastroenterology. 2010 Jul;139(1):48-57.e2. doi: 10.1053/j.gastro.2010.03.049. Epub 2010 Mar 27.</citation>
    <PMID>20347816</PMID>
  </reference>
  <reference>
    <citation>Seminowicz DA, Mikulis DJ, Davis KD. Cognitive modulation of pain-related brain responses depends on behavioral strategy. Pain. 2004 Nov;112(1-2):48-58.</citation>
    <PMID>15494184</PMID>
  </reference>
  <reference>
    <citation>Simrén M, Axelsson J, Gillberg R, Abrahamsson H, Svedlund J, Björnsson ES. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol. 2002 Feb;97(2):389-96.</citation>
    <PMID>11866278</PMID>
  </reference>
  <reference>
    <citation>Sipponen T, Kärkkäinen P, Savilahti E, Kolho KL, Nuutinen H, Turunen U, Färkkilä M. Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings. Aliment Pharmacol Ther. 2008 Nov 15;28(10):1221-9. doi: 10.1111/j.1365-2036.2008.03835.x. Epub 2008 Aug 26.</citation>
    <PMID>18752630</PMID>
  </reference>
  <reference>
    <citation>Song GH, Venkatraman V, Ho KY, Chee MW, Yeoh KG, Wilder-Smith CH. Cortical effects of anticipation and endogenous modulation of visceral pain assessed by functional brain MRI in irritable bowel syndrome patients and healthy controls. Pain. 2006 Dec 15;126(1-3):79-90. Epub 2006 Jul 18.</citation>
    <PMID>16846694</PMID>
  </reference>
  <reference>
    <citation>Spaziani R, Bayati A, Redmond K, Bajaj H, Mazzadi S, Bienenstock J, Collins SM, Kamath MV. Vagal dysfunction in irritable bowel syndrome assessed by rectal distension and baroreceptor sensitivity. Neurogastroenterol Motil. 2008 Apr;20(4):336-42. doi: 10.1111/j.1365-2982.2007.01042.x. Epub 2007 Dec 19. Erratum in: Neurogastroenterol Motil. 2008 May;20(5):576. Mazzadi, S [added].</citation>
    <PMID>18179607</PMID>
  </reference>
  <reference>
    <citation>Spetalen S, Sandvik L, Blomhoff S, Jacobsen MB. Autonomic function at rest and in response to emotional and rectal stimuli in women with irritable bowel syndrome. Dig Dis Sci. 2008 Jun;53(6):1652-9.</citation>
    <PMID>17990112</PMID>
  </reference>
  <reference>
    <citation>Spielberger, C.D., Gorsuch, R., Lushene, R. 1983. The State-Trait Personality Inventory (STAI, Form Y), Palo Alto, CA, Consulting Psychologists Press.</citation>
  </reference>
  <reference>
    <citation>Sullivan, M.J.L., Bishop, S. and Pivik, J. The Pain Catastrophizing Scale: Development and validation. Psychol. Assess. 1995, 7: 524-532.</citation>
  </reference>
  <reference>
    <citation>Summerton CB, Longlands MG, Wiener K, Shreeve DR. Faecal calprotectin: a marker of inflammation throughout the intestinal tract. Eur J Gastroenterol Hepatol. 2002 Aug;14(8):841-5.</citation>
    <PMID>12172403</PMID>
  </reference>
  <reference>
    <citation>Talairach J and Tournoux P,</citation>
  </reference>
  <reference>
    <citation>Tang LY, Nabalamba A, Graff LA, Bernstein CN. A comparison of self-perceived health status in inflammatory bowel disease and irritable bowel syndrome patients from a Canadian national population survey. Can J Gastroenterol. 2008 May;22(5):475-83.</citation>
    <PMID>18478133</PMID>
  </reference>
  <reference>
    <citation>Taylor CT, Keely SJ. The autonomic nervous system and inflammatory bowel disease. Auton Neurosci. 2007 Apr 30;133(1):104-14. Epub 2007 Jan 17. Review.</citation>
    <PMID>17234460</PMID>
  </reference>
  <reference>
    <citation>Thompson SC. Will it hurt less if i can control it? A complex answer to a simple question. Psychol Bull. 1981 Jul;90(1):89-101.</citation>
    <PMID>7267899</PMID>
  </reference>
  <reference>
    <citation>Tibble J, Teahon K, Thjodleifsson B, Roseth A, Sigthorsson G, Bridger S, Foster R, Sherwood R, Fagerhol M, Bjarnason I. A simple method for assessing intestinal inflammation in Crohn's disease. Gut. 2000 Oct;47(4):506-13.</citation>
    <PMID>10986210</PMID>
  </reference>
  <reference>
    <citation>Tibble JA, Sigthorsson G, Bridger S, Fagerhol MK, Bjarnason I. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology. 2000 Jul;119(1):15-22.</citation>
    <PMID>10889150</PMID>
  </reference>
  <reference>
    <citation>van Orshoven NP, Andriesse GI, van Schelven LJ, Smout AJ, Akkermans LM, Oey PL. Subtle involvement of the parasympathetic nervous system in patients with irritable bowel syndrome. Clin Auton Res. 2006 Feb;16(1):33-9.</citation>
    <PMID>16477493</PMID>
  </reference>
  <reference>
    <citation>Van Oudenhove L, Vandenberghe J, Dupont P, Geeraerts B, Vos R, Dirix S, Bormans G, Vanderghinste D, Van Laere K, Demyttenaere K, Fischler B, Tack J. Abnormal regional brain activity during rest and (anticipated) gastric distension in functional dyspepsia and the role of anxiety: a H(2)(15)O-PET study. Am J Gastroenterol. 2010 Apr;105(4):913-24. doi: 10.1038/ajg.2010.39. Epub 2010 Feb 16.</citation>
    <PMID>20160711</PMID>
  </reference>
  <reference>
    <citation>Verma-Gandhu M, Bercik P, Motomura Y, Verdu EF, Khan WI, Blennerhassett PA, Wang L, El-Sharkawy RT, Collins SM. CD4+ T-cell modulation of visceral nociception in mice. Gastroenterology. 2006 May;130(6):1721-8.</citation>
    <PMID>16697736</PMID>
  </reference>
  <reference>
    <citation>Wagner M, Peterson CG, Ridefelt P, Sangfelt P, Carlson M. Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease. World J Gastroenterol. 2008 Sep 28;14(36):5584-9; discussion 5588.</citation>
    <PMID>18810778</PMID>
  </reference>
  <reference>
    <citation>Walach H., Buttenmuller, V., Kleinknecht N., Schmidt S. Measuring mindfulness - the Freiburg Mindfulness Inventory (FMI). Personnality and Individual Differences, 2006, 40:1543-1555.</citation>
  </reference>
  <reference>
    <citation>Weisenberg M, Schwarzwald J, Tepper I. The influence of warning signal timing and cognitive preparation on the aversiveness of cold-pressor pain. Pain. 1996 Feb;64(2):379-85.</citation>
    <PMID>8740617</PMID>
  </reference>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 25, 2016</study_first_submitted>
  <study_first_submitted_qc>August 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 22, 2016</study_first_posted>
  <last_update_submitted>August 16, 2016</last_update_submitted>
  <last_update_submitted_qc>August 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Crohn's disease</keyword>
  <keyword>Rectal Distension</keyword>
  <keyword>Remission</keyword>
  <keyword>Anticipation</keyword>
  <keyword>Painful</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
    <mesh_term>Dilatation, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

